Review of: "The α7 Nicotinic Acetylcholine Receptor: a Key Molecule in Post-COVID Syndrome?"

Simple item page
dc.contributor.authorMiguel Guzmán-Rivero
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:16:45Z
dc.date.available2026-03-22T21:16:45Z
dc.date.issued2023
dc.description.abstractPotential competing interests: No potential competing interests to declare
dc.identifier.doi10.32388/jkz848
dc.identifier.urihttps://doi.org/10.32388/jkz848
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/86991
dc.language.isoen
dc.sourceUniversidad Mayor de San Simón
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectNicotinic acetylcholine receptor
dc.subjectAcetylcholine receptor
dc.subjectAcetylcholine
dc.subjectKey (lock)
dc.subjectNicotinic agonist
dc.subject2019-20 coronavirus outbreak
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectReceptor
dc.subjectChemistry
dc.titleReview of: "The α7 Nicotinic Acetylcholine Receptor: a Key Molecule in Post-COVID Syndrome?"
dc.typepeer-review

Files

Collections

Artículo Científico Publicado